• IDSA updates guidance to support use of tocilizumab for COVID-19

    9 days ago - By Healio

    The Infectious Diseases Society of America has backed the use of tocilizumab for COVID-19.
    In a change to its clinical guidelines, the IDSA now “suggests” the use of tocilizumab - a common rheumatoid arthritis medication - in addition to standard of care treatment such as steroids among patients hospitalized with progressive severe or critical COVID-19, rather than standard of care treatment alone.
    Initial guidance by IDSA recommended against the routine use of tocilizumab in patients hospitalized with COVID-19.
    The change followed the release of new results from the
    Read more ...

     

  • IDSA Reverses on Actemra; 500K COVID Deaths; J&J Says 20M Vax Doses by Spring

    IDSA Reverses on Actemra; 500K COVID Deaths; J&J Says 20M Vax Doses by Spring

    9 days ago - By MedPageToday

    Note that some links may require registration or subscription.
    The Infectious Diseases Society of America changed course on tocilizumab , and now conditionally recommends the IL-6 blocker on top of standard care...
    Read more ...